Our Service
Lipodissolve/Mesotherapy
- Treatment time: 35 to 40 minutes
- $ 350/session per area
- $ 400/session per area
Lipodissolve, also known as lipolysis or mesotherapy, is a minimally invasive procedure that involves a series of chemical injections with short, fine needles that target the middle layer (or mesoderm) of skin for treatment and reduction of small fat pockets. The procedure intended to reduce fat with a series of injectable drugs known as phosphatidylcholine and deoxycholate, also called PCDC.
- Treatment areas include:
- Small amounts of fat such as love handles, back fat, arms, thighs, and abdomen.
FREQUENTLY ASKED QUESTIONS (FAQ)
Phosphatidylcholine (PC) most commonly used agent for fat cell lysis affecting the permeability of the adipocyte membrane for fat mobilization. Deoxycholate or DC breaks down the fat, whereas phosphatidylcholine, or PC, helps with digestion and removal of the broken-down fat. The fat loss experienced with lipodissolve is permanent.
Typically, most patients will need 3-5 sessions about a month apart for the best results.
We cannot treat more than two body areas at the same treatment.
Visible results can be seen as early as 1-2 weeks.
Most people will develop redness, bruising, and swelling in the treatment area, along with moderate discomfort. These symptoms are the most noticeable for the first 3 days after the treatment.
Allergy to soy and egg yolks allergy. Phosphatidylcholine (PC) used in mesotherapy is soy in origin and egg yolks, pregnancy or breast feeding, immuno-compromised, liver and renal failure, microangiopathy, peripheral artery disease, and vascular insufficiency, autoimmune except Hashimoto’s and rheumatoid arthritis, anticoagulant agents, hemophiliacs, active infection in the treated area and history of scarring/pigmentation after injections.
Lipodissolve is not FDA-approved. However, each component of PC/DC is FDA-approved for other indication. The main substance in Lipodissolve, PC/DC, is made by compounding pharmacy. The PC/DC is typically made by a FDA-registered 503a or 503b facility.
